Meningiomas are the most common primary tumors in central nervous system. While recent studies have revealed genetic clues to lower grade human meningiomas, the molecular determinants driving the progression and recurrence of anaplastic meningioma, the most malignant subtype with a low prevalence but high morbidity, are still poorly understood. It has been proposed that high recurrence rates of malignant meningiomas are linked to cancer stem cells. Indeed, tumor stem-like cells have been isolated from various meningioma subtypes, but never been obtained from anaplastic meningioma. In this study, we successfully isolated stem-like cells from human anaplastic meningioma. These cells are capable of forming spheres and initiating xenograft tumors that recapitulate anaplastic meningioma phenotypes, and thus could serve as an in vitro model for malignant meningiomas. KLF4, a transcription factor known for its role in stemness maintenance, was identified as one of the most frequently mutated genes in the benign secretory meningioma. Interestingly, we found that KLF4 is downregulated in anaplastic meningioma compared with low-grade meningioma subtypes. By manipulating KLF4 expression in anaplastic meningioma stem-like cells, we demonstrated that KLF4 acts as a tumor suppressor during malignant progression in meningioma, affecting apoptosis, proliferation, invasion, and cell cycle. These results suggest a potential therapeutic value of KLF4 for clinical intervention of anaplastic meningioma.
Introduction
Meningiomas arise from arachnoidal cells of the leptomeninges covering the brain and spinal cord, and account for~30% of all central nervous system (CNS) tumors (Riemenschneider et al., 2006; Mawrin and Perry, 2010) . Most meningiomas are slow-growing benign brain tumors, belonging to World Health Organization (WHO) grade I, which show a favorable prognosis after surgical removal (Jurić et al., 2013) . About 20% of meningiomas are malignant tumors, classified as WHO grade II (such as atypical meningioma) or grade III (such as anaplastic meningioma) (Louis et al., 2016) , which are more aggressive and have a higher risk of recurrence after resection, causing increased morbidity and mortality (Willis et al., 2005) . Surgical resection and radiotherapy are the only established treatments to meningiomas, but the 5-year survival from anaplastic meningioma, even after extensive treatment with radiotherapy and/ or stereotactic radiosurgery, is still low (Sughrue et al., 2010; Walcott et al. 2013; Zhu et al. 2015) . These bring to a clear clinical necessity for a better understanding of molecular mechanisms driving malignant progression and recurrence in meningioma, which may introduce novel medical options for the therapy of malignant meningiomas.
An emerging paradigm suggests that a variety of human tumors originate from stem-like cells (Rowland and Peeper, 2006) . These so-called cancer stem cells are thought to drive tumor initiation, invasion, and metastasis. Moreover, they are thought to be associated with cancer recurrence and chemoresistance or radioresistance. Indeed, stem-like cells have been isolated from human WHO grade I, grade II, and rhabdoid (WHO grade III) meningiomas, which could initiate tumor formation when injected into murine brain and were resistant to radiation in vitro (Hueng et al., 2011; Rath et al., 2011; Hu et al., 2012; Lim et al., 2013) . However, such stem-like cells were never isolated from anaplastic meningioma, a WHO grade III meningioma subtype. Thus, the origin nature and molecular determinants of anaplastic mengioma are not well understood so far.
A genomic analysis of 300 meningiomas identified a high mutation rate in kruppel-like factor 4 (KLF4), as well as TRAF7, AKT1, and SMO (Clark et al., 2013) . Further investigation revealed that a lysine to glutamine mutation at codon 409 (K409Q) of KLF4 was exclusively detected in secretory meningiomas, a WHO grade I meningioma subtype, implying a potential highly specific diagnostic marker (Reuss et al., 2013) . KLF4 is a DNA-binding transcriptional regulator that is involved in a variety of cellular processes including proliferation, differentiation, apoptosis, and somatic cell reprogramming, thus contributing to both health and diseases (Takahashi et al. 2007; McConnell and Yang, 2010; Shields et al., 2010) . In particular, the roles of KLF4 in cancer can be opposite and context-dependent (Rowland and Peeper, 2006) . For instance, KLF4 acts as a tumor suppressor in breast and colon cancer (Dang et al., 2003; Akaogi et al., 2009; Ghaleb et al., 2016) but shows a tumor-promoting role in pancreatic cancer (Guo et al., 2017) . Recent studies also indicate that KLF4 may contribute to the progression of glioma by transcriptionally repressing another transcription factor FOXO1 (Tang et al., 2016) . However, whether KLF4 is involved in the pathogenesis of human meningiomas other than benign secretory meningioma, in particular the rarely studied anaplastic meningioma, still remains unclear.
In this study, to identify whether tumor stem-like cells exist and the role of KLF4 in anaplastic meningioma, we isolated anaplastic meningioma stem-like cells that were used as an in vitro model for malignant meningiomas. We further showed tumorsuppressing effects of KLF4 on these highly tumorigenic cells, suggesting a novel role of KLF4 as tumor suppressor in anaplastic meningioma progression.
Results

Isolation and characterization of stem-like cells from anaplastic meningioma
To investigate whether tumor stem-like cells exist in anaplastic meningioma, 10 surgical specimens of human anaplastic meningioma were collected for cell isolation. These patients suffered from headache and dizziness for~6 months. Their general clinical information is provided in Table 1 , and more details of the representative case (Patient N13-1792) are shown here. The preoperative brain magnetic resonance imaging (MRI) showed a large, extensive tumor with apparent enhanced signal located on right temporal and middle skull base ( Figure 1A and B). The tumor under macroscopic inspection exhibited meningioma morphology, with rich vascular supply and firm in consistency ( Figure 1C) . The tumor was completed removed by surgical resection ( Figure 1D) , and postoperative histopahological examinations on the biopsies were carried out ( Figure 1E-H) . Specifically, the tumor exhibited marked nuclear heteromorphy and mitoses ( Figure 1E ), expressed human epithelial membrane antigen (EMA) ( Figure 1F ) and vimentin ( Figure 1G ), and had a high proliferation index indicated by >15% MIB-1-positive nuclei ( Figure 1H ). In addition, the tumor was partial positive for progestin receptor, but negative for glial fibrillary acidic protein or hematopoietic progenitor marker CD34 (data not shown). These results confirm the diagnosis of a human anaplastic meningioma (WHO grade III) case.
Spheroids are supposedly derived from single neural and cancer stem cells, and progressive self-renewal expands the proportion of stem cells within these spheroids. To derive primary stem-like cells from anaplastic meningioma biopsies, we adopted spheroid culture method as previously described (Reynolds and Weiss, 1992; Tang et al., 2012) . Again, representative data from the case of Patient N13-1792 are shown. The resected anaplastic meningioma tumor tissue was dissociated into single cells, and 50000 cells were seeded in nonadherent culture vessels in serum-free stem cell culture medium. The next day, cells began to gather into small spheres ( Figure 2A ). These spheres had differentiation potential, which displayed a spindle-shaped, adherent phenotype to differentiate soon after being cultured in medium with serum ( Figure 2B ). The primary spheres were gently dissociated into single cells and maintained in serum-free stem cell culture medium. The single cells formed secondary spheres after 5-7 days and were able to form further generations of spheres by continuous passaging, indicating the self-renewal property of these anaplastic meningioma-derived stem-like cells.
In addition, the spheres and dissociated cells were specifically positive for the stem cell markers CD133 ( Figure 2C ) and PDG2 ( Figure 2D ), but were negative for the neuronal progenitor marker nestin or hematopoietic progenitor marker CD34 (data not shown). These cells were differentiated in serum-containing medium to express vimentin ( Figure 2E ) and weak EMA (data not shown), suggesting a similar cell marker expression profile as the primary tumor. Moreover, these cells showed Ki-67-positive nuclei ( Figure 2F ), suggesting their proliferative capacity.
We have successfully isolated and characterized 10 lines of anaplastic meningioma stem-like cells. In this study, cells derived from the anaplastic meningioma specimen of Patient N13-1792 were used for the following experiments.
Anaplastic meningioma stem-like cells are tumorigenic in nude mice
We next investigated in vivo tumorigenicity of these anaplastic meningioma stem-like cells in a mouse xenograft model (Kalamarides et al., 2010) . Two weeks after subcutaneously inoculation of 1 × 10 5 anaplastic meningioma stem-like cells into the flank of nude mice, subcutaneous tumors were visible. The tumors were measured at~2.3 mm in diameter 3 weeks after inoculation. Mice were sacrificed at Week 7 when a mass was formed at the injection site. The subcutaneous xenograft tumors were collected and processed for histopathological analysis. These tumors showed similar histological features as the parental human anaplastic meningioma tumor ( Figure 3A) , as well as strong positive immunoreactivity of EMA ( Figure 3B ) and vimentin ( Figure 3C ). These results indicate that the isolated anaplastic meningioma stem-like cells possess highly tumorigenic property and initiate xenograft tumors histologically recapitulating human anaplastic meningioma features in vivo.
KLF4 is downregulated in anaplastic meningioma compared with low-grade meningiomas We analyzed the expression of KLF4 mRNA in a series of primary meningioma tissues in comparison with nonneoplastic arachnoidal tissue ( Figure 4 ). All tumor tissues expressed KLF4 whereas nonneoplastic tissue showed a very low KLF4 level. When the tumors were separated according to their WHO grades, significantly lower KLF4 expression was detected in malignant atypical (WHO grade II) and anaplastic (WHO grade III) meningiomas compared with benign fibroblastic and meningothelial meningiomas (WHO grade I). Moreover, KLF4 expression was further downregulated in anaplastic meningiomas compared with atypical meningiomas. Thus, higher KLF4 expression associates with more benign meningioma subtype, while lower KLF4 expression associates with more malignant meningioma subtype, which suggests that KLF4 may act as a tumor suppressor in human meningioma.
KLF4 increases apoptosis, reduces proliferation and invasion, and disrupts cell cycle progression of anaplastic meningioma stem-like cells
To clarify the potential antitumor role of KLF4 in anaplastic meningioma stem-like cells, KLF4 knockdown and KLF4-overexpressing cells were reconstituted using stable lentiviral transfection with Lv-KLF4-shRNA and Lv-KLF4, respectively. The KLF4 protein level after 72 h of lentivirus infection was determined by western blotting, which indicated effectively silenced or enhanced KLF4 expression without unexpected off-target effect ( Figure 5A) . These cells were then collected for apoptosis measurement. The results showed that KLF4 silencing significantly reduced apoptosis, while KLF4 overexpression significantly enhanced apoptosis ( Figure 5B ). In contrast, KLF4 knockdown facilitated cell proliferation ( Figure 5C , 48 and 72 h), colony formation ( Figure 5D ), and cell invasion ( Figure 5E ), while KLF4 overexpression inhibited these tumorigenic properties of anaplastic meningioma stem-like cells ( Figure 5C -E). Moreover, cell cycle analysis showed that KLF4 silencing facilitated cells from G1 phase entering into S phase, while KLF4 overexpression arrested cells in G1 phase ( Figure 6F ).
Consistently, the protein levels of p21, p53, and BAX, the known tumor suppressors involved in apoptosis, proliferation, and/or cell cycle-related signaling pathways, were markedly decreased in KLF4 knockdown cells, but significantly increased in KLF4-overexpressing cells ( Figure 5G ). These data suggest that KLF4 exerts a tumor-suppressing function in human anaplastic meningioma stem-like cells, probably via regulating other tumor suppressors such as p21, p53, and BAX.
KLF4 suppresses xenograft tumor formation by anaplastic meningioma stem-like cells in nude mice
The antitumor function of KLF4 was also characterized in vivo. The anaplastic meningioma stem-like cells without lentivirus infection or infected with Lv-NC, Lv-shRNA-KLF4 (KLF4 knockdown cells), or Lv-KLF4 (KLF4-overexpressing cells) were injected into the flanks of nude mice. The formation of subcutaneous xenograft tumors was monitor and the tumor size was measured weekly from Week 3 ( Figure 6A ). Seven weeks after inoculation, the mice were sacrificed and the xenograft tumors were collected ( Figure 6B) . By measuring the diameter of each xenograft tumor and further calculating, the average tumor volume in each group was determined as 907. Figure 6A ). These results indicate that KLF4 significantly suppresses xenograft tumor formation by anaplastic meningioma stem-like cells. Since cyclin D1, MMP-9, and BCL-2 are crucial regulators in cell cycle, invasion, and apoptosis, respectively, we further assessed the protein levels of KLF4 and these molecules in xenograft tumors to determine the signaling pathways involved. As shown in Figure 6C , KLF4 expression level in the xenograft tumors is negatively associated with the levels of cyclin D1, MMP-9, and BCL-2, suggesting that KLF4 acts as a tumor suppressor via affecting cell cycle, invasion, and apoptosis.
Discussion
Our results demonstrate, for the first time, that cancer stemlike cells exist in anaplastic meningioma and KLF4 may act as a tumor suppressor in human meningioma progression and recurrence. First, stem-like cells are isolated from human anaplastic meningioma and characterized for self-renewal and tumorigenicity. Second, KLF4 is downregulated in anaplastic meningioma compared with lower grade meningioma subtypes, suggesting its role as a negative factor to the malignant progression of meningioma. Third, genetic manipulation targeting KLF4 in anaplastic meningioma stem-like cells indicates a tumor-suppressing role of KLF4 in initiation and progression of anaplastic meningioma.
Anaplastic meningioma (WHO grade III) accounts for 1%-2% of all meningiomas, but has considerable clinical outcomes with an average survival of <2 years, 5-year overall survival <60%, and 10-year overall survival <34% without any progression-free survival (Sughrue et al., 2010; Walcott et al., 2013; Zhu et al., 2015; Bi et al., 2016) . Compared with other lower grade meningioma subtypes that have been well studied for both histopathological features and molecular alterations, the knowledge points toward the true nature of human anaplastic meningioma is completely missing. Scarcity of clinical cases of anaplastic meningioma may be the main limiting factor leading to the circumstance. High recurrence rates of malignant tumors are often linked to the infiltration into the adjacent tissue driven by cancer stem cells (Ishiwata, 2016) . However, there was no direct evidence yet supporting the existence of such cells in anaplastic meningioma. Thus, our work that isolated anaplastic meningioma stem-like cells is particularly important to answer this question, i.e. stem-like, tumor-initiating cells do exist in anaplastic meningioma, which may contribute to the malignancy and recurrence.
On the other hand, high malignancy and recurrence rate of anaplastic meningioma makes it an ideal model, irrespective of availability, to explore the molecular mechanisms driving malignant progression and recurrence of human meningiomas, and to evaluate the effects of innovative therapeutic strategies. The isolated anaplastic meningioma stem-like cells could be maintained for long-term passaging, generate stable lines with genetic manipulation, and initiate xenograft tumors reproducing histological features of human anaplastic meningioma. Therefore, they could be a promising in vitro model for meningioma study, for instance as a high-throughput screening platform to identify novel molecules that are involved in tumorigenesis and thus may be potential diagnosis markers or therapeutic targets.
It is important to note that the effects of KLF4 on tumoriogenesis are highly context specific (Dang et al., 2003; Rowland and Peeper, 2006; Akaogi et al., 2009; Ghaleb et al. 2016; Guo et al., 2017) . Indeed, oncogenic gain-of-function mutation in KLF4 has been identified as a key driving event in benign secretory meningiomas (Reuss et al., 2013) . However, in all malignant anaplastic meningioma samples we examined in this study, no meaningful loss-of-function KLF4 mutation was found, which is consistent with previous finding that the KLF K409Q mutation is exclusively seen in secretory meningioma (Clark et al., 2013; Reuss et al., 2013) , suggesting a mechanism independent of genetic mutation. Given the core role of KLF4 in maintaining stemness and reprogramming somatic cells into induced pluripotent stem cells (Shi and Ai, 2013) , we hypothesize that stemness maintenance and/or reprogramming by the pluripotent stemness factors, e.g. KLF4, rather than specific genetic mutation of KLF4, may be the determinant of malignance and recurrence of human meningioma. Indeed, KLF4 has been reported Figure 4 KLF4 is downregulated in anaplastic meningioma compared with low-grade meningioma subtypes. KLF4 mRNA levels in fibroblastic meningioma (WHO grade I, n = 10), meningothelial meningioma (WHO grade I, n = 9), atypical meningioma (WHO grade II, n = 12), anaplastic meningioma (WHO grade III, n = 6), as well as arachnoid tissue (n = 6) were analyzed by qRT-PCR. Data are mean ± SD of relative KLF4 mRNA levels, expressed as a ratio normalized to beta actin. *P < 0.05, **P < 0.01.
Figure 5 KLF4 increases apoptosis, decreases proliferation, colonogenicity, and invasion, and disrupts cell cycle of anaplastic meningioma stem-like cells. Anaplastic meningioma stem-like cells after genetic manipulation by indicated lentivirus infection for 72 h were examined for KLF4 expression levels by western blotting (A), cell apoptosis by flow cytometry (B), cell proliferation by CCK-8 assay (C), colony formation (D), cell invasion by Transwell assay (E), cell cycle distributions by flow cytometry (F), and protein levels of p21, p53, and BAX by western blotting (G). Data are representative of three or four independent experiments and expressed as mean ± SD (n = 3 in A, B, G; n = 4 in C-F). *P < 0.05 and **P < 0.01 vs. control or Lv-NC.
as the key component of the pluripotency transcription network for primary human colon cancer cell reprogramming to promote metastases (Singovski et al., 2016) . It seems that the reprogramming of anaplastic meningioma stem-like cells could not result in pluripotent stem cells but still stem-like cells that differentiate and form meningioma tumors. Thus, the stemness of these cells may be crucial. How KLF4 affects the stemness of anaplastic meningioma stem-like cells and the consequent malignance of meningioma needs further investigations.
In our study, KLF4 expression in tumor tissue was downregulated in anaplastic meningioma compared with WHO grade I or II meningiomas. However, whether and how KLF4 is differentially expressed in the tumor stroma are not clear. Since KLF4 is important in maintaining cell stemness, it is also possible that KLF4 is upregulated specifically in anaplastic meningioma stemlike cells as a protective, inhibitory mechanism, but these cells may be low in number in malignant meningioma tissue. To address these concerns, further analysis of KLF4 expression in the meningioma stroma of each patient will be necessary. And a comprehensive expression profiling of KLF4 and other related molecules covering a series of stem-like cells derived from various meningioma subtypes is required in the future.
In addition, here we assessed the effects of KLF4 manipulation in a cell-autonomous fashion and as such we cannot comment on the effects of KLF4 manipulation on the meningioma microenvironment. Indeed, KLF4 exerts important vasculoregulatory actions, and the microvascular niche is a key regulator of stemness in brain tumors (Reuss et al., 2013) . Therefore, assessment of KLF4 manipulation on the meningioma microenvironment is important if it is to be pursued as a therapeutic target in human meningioma. etic manipulation were subcutaneously injected into nude mice for xenograft tumor formation. These mice were divided into four groups: model group injected with noninfected control cells (11 mice), Lv-NC group with control lentivirus-infected cells (6 mice), Lv-shRNA-KLF4 group with KLF4 knockdown cells (6 mice), and Lv-KLF4 group with KLF4-overexpressing cells (6 mice). (A) The subcutaneous tumors were measured weekly since Week 3 to generate xenograft tumor growth curves. Data are mean ± SD of calculated subcutaneous tumor volume (n = 6). (B) Representative xenograft tumors extracted from the mice sacrificed at Week 7 after inoculation of anaplastic meningioma stemlike cells. (C) The extracted xenograft tumors from different groups were examined for protein levels of KLF4, cyclin D1, MMP-9, and BCL-2 by western blotting. Representative blots are shown. Data are mean ± SD of relative protein levels, expressed as a ratio normalized to beta actin (n = 3). *P < 0.05 and **P < 0.01 vs. model or Lv-NC.
In summary, our study establishes tumor stem-like cells from anaplastic meningioma and identifies KLF4 as a potential tumor suppressor in human meningioma. These results provide an efficient in vitro platform to identify and evaluate molecular targets in human meningioma, in particular the rarely available anaplastic meningioma, and suggest the therapeutic potential of KLF4 in clinical adjuvant treatment strategy for anaplastic meningioma.
Materials and methods
Anaplastic meningioma tumor specimens
Tumor tissues were collected from 10 patients during surgical resection. All specimens were subjected to postoperation pathological examination. A double-blind malignant meningioma grading, carried out by two experienced pathologists following the method described by Willis et al. (2005) , confirmed that all cases belong to anaplastic meningioma (WHO grade III). More patient information is provided in Table 1 . The imaging and histological results of Patient N13-1792 were displayed in Figure 1 . The study was conducted with written informed consent from all patients and under supervision of Shanghai Huashan Hospital Ethics Committee.
Primary meningioma cell isolation and neurosphere culture
Freshly resected tumor tissues from each patient were kept individually in medium in a sterile test tube at 4°C. Primary meningioma cells were isolated using a comprehensive digestion method and maintained in a culture system as described previously (Reynolds and Weiss, 1992; Tang et al., 2012) . Briefly, anaplastic meningioma tissue was dissociated into single cells and 50000 cells were seeded in nonadherent culture vessels in serum-free neurosphere medium as previously described (Reynolds and Weiss, 1992; Tang et al., 2012) . Ten stable lines of primary meningioma cells were obtained and characterized. If not otherwise mentioned, the data show here were obtained from experiments using cells derived from the tumor sample of Patient N13-1792.
Immunocytochemistry
Cells passed for 10 generations were examined for CD133, vimentin, EMA, nestin, PDG2, Ki-67, and CD34 by immunocytochemistry staining as previously described (Tang et al., 2012) . The primary antibodies were all obtained from Abcam.
Histology and immunohistochemistry
Both human and mouse tumor specimens were processed for histological examination by standard H&E staining and examined for EMA, vimentin, and Ki-67 (detected by MIB-1 antibody) by IHC staining (Bleau et al., 2008) . The primary antibodies were all obtained from Abcam.
Lentiviral infection of anaplastic meningioma stem-like cells
Total human RNA was extracted by using Trizol, and reversely transcribed into cDNA, which was used for PCR amplification of KLF4 gene (NM_004235), using the primers as follows: KLF4-forward: 5′-GCTCTAGA(XbaI)GCCACC(kozak)ATGAGGCAGCCACCTGGC-3′; KLF4-reverse: 5′-CGGGATCC(BamHI)TTAAAAATGCCTCTTCATGTG-3′. The product was cloned into pcDH-GFP Lentivector (CD511A-1, System Biosciences) to construct the KLF4 expression vector pcDH-KLF4. A siRNA sequence, 5′-GCAGCTTCACCTATCCGAT-3′, was designed by using online software according to the information of KLF4 gene. Two complementary DNA sequences were designed and synthesized, each including the sense and antisense sequences of shRNA, a loop 5′-CTTCCTGTCAGA-3′, a termination signal of RNA polyIII (TTTT), as well as XhoI and EcoRI cutting sites. The synthetic sequences, 5′-TCGAGGCAGCTTCACC TATCCGATCTTCCTGTCAGAATCGGATAGGTGAAGCTGCTTTTTG-3′ and 5′-AATTCAAAAAGCAGCTTCACCTATCCGATTCTGACAGGAAGATCGGAT AGGTGAAGCTGCC-3′, were annealed and cloned into a shRNA expression vector, pSIH1-H1-GFP shRNA Vector (SI501A-1, System Biosciences), to construct pSIH1-KLF4 targeting KLF4 gene. A missense sequence 5′-GAAGCCAGATCCAGCTTCC-3′ was used as the negative control for gene silencing. The endotoxin-free plasmids of the recombinant vectors (pSIH1-NC, pSIH1-KLF4, and pcDH-KLF4) were prepared after being verified by sequencing and co-transfected with pPACK Packaging Plasmid Mix (System Biosciences) into 293TN cells to produce the lentiviruses of Lv-shRNA-KLF4, Lv-NC, and Lv-KLF4. The packaging and titer measurement were performed completely in accordance with the instruction of the kit.
Anaplastic meningioma stem-like cells cultured for 7 days were trypsinized, resuspended, and seeded into 6-well plates and cultured under the same conditions as before. The cells were divided into four groups that were infected with different lentiviruses: control (noninfected), Lv-NC, Lv-shRNA-KLF4, and Lv-KLF4. Cultured overnight, the cells were added with corresponding lentiviral solution at MOI = 40, and cultured for 72 h. Then, the cells were collected and subjected to western blotting for KLF4 levels to determine the efficiency of genetic manipulation. Cells after 72 h were also collected to examine cell cycle, apoptosis, cell proliferation, colony formation, and cell invasion and were used for animal xenograft experiments.
Cellular proliferation assay
Anaplastic meningioma stem-like cells were trypsinized, resuspended, and seeded into 96-well plates at a density of 5 × 10 4 cells per well. The cells were cultured under normal conditions, and cell viability was examined using CCK-8 at time points of 12, 24, 48, and 72 h. Briefly, 10 μl CCK-8 solution (Dojindo) was added to the cells. After culture for an additional 4 h, the absorbance at 450 nm was measured.
Colony formation assay
Anaplastic meningioma stem-like cells were trypsinized, resuspended, and seeded into 10-cm culture plates at a density of~100 cells per plate in 10 ml medium. The culture condition was the same as that used for initial culture of stem-like cells. The medium was replaced every three days and was removed on Day 15. Then the cells were subjected to giemsa staining and photographed. The number of cell clones with a diameter of 0.3 mm was counted, and intergroup analysis was conducted.
Cell invasion assay
Cell invasion assays were performed using the QCMTM 24-well Fluorimetric Cell Invasion Assay Kit (ECM554, Chemicon International) according to the manufacturer's instructions.
Cell cycle analysis
Anaplastic meningioma stem-like cells were trypsinized, resuspended, washed with phosphate-buffered saline (PBS) twice, and then fixed with 70% ethanol at 4°C overnight. The fixed cells were washed with PBS twice, resuspended in 100 μl PBS containing 100 μg/ml ribonuclease A and 50 μg/ml propidium idide, and incubated at room temperature for 30 min. The cell suspensions were analyzed for cell cycle on a BD FACSCalibur flow cytometer.
Cell apoptosis analysis
In the genetic manipulation experiment, anaplastic meningioma stem-like cells were collected after 72 h and subjected to flow cytometry using the Annexin V:FITC Apoptosis Detection Kit II (Cat: 556570, BD) according to the manufacturer's instructions. Apoptosis was analyzed on BD FACSCalibur using FITC (FL1) channel and PI (FL2) channel at an excitation wavelength at 488 nm.
Animal xenografts
Animal experiments were performed under the guide of Institutional Animal Care and Use Committee of Fudan University, Shanghai, China. For in vivo tumorigenicity study, 1 × 10 5 cells suspended in 200 μl medium were injected subcutaneously into the flank regions of 29 female athymic nude mice (Kalamarides et al., 2010 ) that were divided into 4 groups: 11 mice in model group receiving noninfected control cells, 6 mice receiving cells infected with Lv-NC, 6 mice receiving cells infected with Lv-shRNA-KLF4, and 6 mice receiving cells infected with Lv-KLF4. After 2 weeks, the tumor diameter was measured weekly to plot tumor growth curves. Mice were sacrificed after 7 weeks, and tumor samples were collected for the examination of KLF4, cyclin D1, MMP-9, and BCL-2 levels by western blotting. Tumor samples of 5 mice in model group were used for histological analysis.
Quantitative reverse transcriptase-polymerase chain reaction analysis KLF4 expression levels in frozen tissues of 10 fibroblastic meningiomas, 9 meningothelial meningiomas, 12 atypical meningiomas, and 6 anaplastic meningiomas were measured by quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) as described previously (Pfaff, 2001) . Briefly, total RNA was prepared from tissues using Trizol reagent (Abmion). The forward and reverse primers of KLF4 were 5′-TCTCTATGTGGTA CAGCCG-3′ and 5′-TGATCCGGGTTCTTACCT-3′, respectively. Complementary DNA synthesis and quantitative analysis were performed with Super Script_Reverse Transcriptase (Invitrogen) according to the manufacturer's protocol. Amplification was performed using the ABI ViiA7 Real Time System (Applied Biosystems) by means of incorporation of SybrGreen fluorescent dye. The cycle threshold (Ct) value was calculated, and the 2 −ΔΔCt method [ΔCt = Ct (KLF4) -Ct (β-actin)] was followed to quantify the relative expression of KLF4.
Detection of protein contents in cells or tissues
The total protein was extracted from cells using M-PER mammalian protein extraction reagent (Pierce) or from tumor tissues using T-PER tissue protein extraction reagent (Pierce). Equal amounts of 15 μg protein determined by a bicinchoninic acid (BCA) protein assay kit (Pierce) were separated on 11% SDS-PAGE gels and transferred onto nitrocellulose membranes. The blots were probed with monoclonal antibodies against human KLF4 (1:350), cyclin D1 (1:500), MMP-9 (1:250), BCL-2 (1:400), and beta actin (1:1200) (Santa Cruz), followed by the secondary HRP-conjugated anti-mouse/rabbit antibody (Santa Cruz). After washing, the bands were detected by chemiluminescence and imaged with X-ray films. Beta actin was used as an endogenous reference for normalization.
Statistical analyses
SPSS 16.0 software was used to analyze the differences between experimental groups. Quantitative data are presented as mean ± SD, and the differences between two groups were compared by the two-tailed Student's t-test. P-values < 0.05 were considered statistically significant.
